Evaluating HSP90AA1 as a predictive biomarker for prognosis in lung adenocarcinoma
These findings show that silencing <i>HSP90AA1</i> expression or using <i>HSP90AA1</i> inhibitors effectively improves treatment outcomes for LUAD. Targeting <i>HSP90AA1</i> could be a powerful treatment strategy for LUAD.
Authors
- Shi Xiang (ORCID: https://orcid.org/0000-0001-8139-5056)
- Zhichao Wang (ORCID: https://orcid.org/0000-0002-9816-5158)
- Wenwen Zhang (ORCID: https://orcid.org/0000-0003-1285-3118)
- Chao Yang (ORCID: https://orcid.org/0000-0002-2502-3861)
- Hui Chen (ORCID: https://orcid.org/0000-0002-7622-8867)
Institutions
- Jiangxi University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-05-01
- DOI
- https://doi.org/10.21037/tcr-24-2155
- Citations
- 3
- Primary Topic
- Heat shock proteins research
- Type
- article
- Field-Weighted Citation Impact
- 2.42